Teacher Retirement System of Texas Makes New $13.50 Million Investment in Tempus AI, Inc. (NASDAQ:TEM)

Teacher Retirement System of Texas acquired a new position in shares of Tempus AI, Inc. (NASDAQ:TEM) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 400,000 shares of the company’s stock, valued at approximately $13,504,000. Teacher Retirement System of Texas owned approximately 0.25% of Tempus AI at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of TEM. GSA Capital Partners LLP acquired a new position in Tempus AI during the third quarter worth $306,000. First Horizon Advisors Inc. acquired a new position in Tempus AI during the third quarter worth $30,000. The Manufacturers Life Insurance Company grew its holdings in shares of Tempus AI by 10.2% during the third quarter. The Manufacturers Life Insurance Company now owns 29,789 shares of the company’s stock worth $1,686,000 after purchasing an additional 2,765 shares during the last quarter. Captrust Financial Advisors bought a new stake in shares of Tempus AI during the third quarter worth $2,726,000. Finally, NEA Management Company LLC grew its holdings in shares of Tempus AI by 17.8% during the third quarter. NEA Management Company LLC now owns 5,385,979 shares of the company’s stock worth $304,846,000 after purchasing an additional 813,169 shares during the last quarter. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

TEM has been the topic of several research analyst reports. Bank of America increased their target price on Tempus AI from $54.00 to $60.00 and gave the stock a “neutral” rating in a report on Monday, March 3rd. TD Cowen restated a “buy” rating and set a $74.00 target price (up previously from $58.00) on shares of Tempus AI in a report on Wednesday, February 5th. Needham & Company LLC increased their target price on Tempus AI from $56.00 to $70.00 and gave the stock a “buy” rating in a report on Tuesday, February 25th. Piper Sandler decreased their target price on Tempus AI from $70.00 to $55.00 and set a “neutral” rating on the stock in a report on Tuesday, March 4th. Finally, William Blair restated a “market perform” rating on shares of Tempus AI in a report on Tuesday, February 25th. Six analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $61.18.

Tempus AI Trading Up 6.9 %

NASDAQ:TEM opened at $51.35 on Friday. Tempus AI, Inc. has a 1-year low of $22.89 and a 1-year high of $91.45. The business’s 50-day moving average price is $56.35 and its two-hundred day moving average price is $51.40. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55.

Insider Buying and Selling at Tempus AI

In other Tempus AI news, Director Jennifer A. Doudna sold 1,320 shares of the stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $90.00, for a total value of $118,800.00. Following the transaction, the director now owns 36,011 shares of the company’s stock, valued at approximately $3,240,990. This represents a 3.54 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CAO Ryan M. Bartolucci sold 13,770 shares of the stock in a transaction dated Friday, January 31st. The shares were sold at an average price of $60.00, for a total value of $826,200.00. Following the completion of the transaction, the chief accounting officer now directly owns 57,237 shares in the company, valued at $3,434,220. The trade was a 19.39 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 5,598,969 shares of company stock valued at $317,194,162.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.